ICUI
ICU Medical Announces Q3 2026 Results and Reaffirms Fiscal 2026 Guidance
ICU Medical reported Q3 2026 GAAP revenue of $560.4 million and reaffirmed its fiscal year 2026 guidance range for net income ($73-$83 million) and diluted EPS ($2.89-$3.29).